Neos Therapeutics, Inc. Announces Settlement Of Pending Patent Litigation Concerning Its Amphetamine Polistirex XR-ODT (NT-0202) With Shire LLC

By: via Benzinga
Neos Therapeutics, Inc. ("Neos"), a specialty pharmaceutical company with a portfolio of novel and proprietary oral drug ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.